| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2902266 | Chest | 2009 | 9 Pages |
Abstract
Infliximab appears superior to systemic corticosteroids with or without additional agents for the treatment of lupus pernio. Noninfliximab, noncorticosteroid-containing regimens are of limited use for this condition.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Eleni MD, William K. PhD, Daniel T. DrPH, Marc A. MD, FCCP,